Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-16-570148
Filing Date
2016-04-29
Accepted
2016-04-29 17:27:05
Documents
7
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d160523d10ka.htm 10-K/A 85115
2 EX-10.11 d160523dex1011.htm EX-10.11 428959
3 EX-31.3 d160523dex313.htm EX-31.3 2294
4 EX-31.4 d160523dex314.htm EX-31.4 2571
5 EX-32.3 d160523dex323.htm EX-32.3 2703
6 EX-32.4 d160523dex324.htm EX-32.4 2714
7 GRAPHIC g111873image001.jpg GRAPHIC 6624
  Complete submission text file 0001193125-16-570148.txt   534757
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8794
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37471 | Film No.: 161608579
SIC: 8731 Services-Commercial Physical & Biological Research